UBX: Unity Biotechnology, Inc. Operating Profitability

Corporate company logo of Unity Bio (UBX)

Unity Biotechnology develops senolytics to combat aging, leveraging robust patent protection and a debt-free balance sheet. Its innovative platform for clearing senescent cells from the body promises a monopoly status for the therapy. An operational profitability assessment by GURU.Markets produces this chart, where 0.00 characterizes this specific valuation parameter. The company is currently seeking strategic R&D partners due to limited liquidity.

Unity Biotechnology, Inc. (UBX): Operating Profitability from 07/04/2022 to 07/19/2025

Summary analytical data breakdowns for Unity Biotechnology, Inc. (UBX)

Fundamental company analysis:Unity Biotechnology Inc.
Finished products of unitybiotechnology.com

Operating margin measures the share of profit from core operations relative to total revenue, demonstrating cost management efficiency before accounting for taxes and interest obligations. For Unity Biotechnology (UBX), which lacks commercial products and relies on clinical trials to compete, the operating profitability trend serves as an indicator of the capital burn rate while protecting patents.

Main competitors

Operating Sales Margin TEM|QGEN - Operating Profitability Margin|Operating Margin IONS|RGEN - Operating Return on Sales|Operating Profitability Avidity RNA|Operating Margin CRISPR Therapeutics Corp CRSP|GeneDx Corp - Operating Margin|Ultragenyx Pharma (RARE) - Operating Sales Margin|beamtx.com (BEAM) - Operating Profitability|SRPT: Operating Profit Ratio|Operating Sales Margin TWST|TXG - Operating Profitability Margin|Operating Margin NTLA|Profitability of Operations Stoke Therapeutics|Operating Profitability BioLife Solutions BLFS|Wave Life Sciences (WVE) - Operating Return on Sales|Maze Therapeutics, Inc. - Operating Margin|Profitability of Operations Sionna Therapeutics, Inc. SION|Prime Medicine Bio (PRME) - Operating Profitability|TSHA: Operating Profit Ratio|Operating Profitability uniQure Pharma|MGTX - Operating Profitability Margin|Operating Margin RGNX|Operating Profitability SLDB (Solid Biosciences)|Ocugen Corp - Operating Sales Margin|PACB: Return on Sales by Operating Profit|benitec.com - Operating Margin|DSGN - Operating Margin|RCKT: Operating Margin|FDMT (4D Molecular Therapeutics Inc) - Operating Profitability|Operating Sales Margin LXEO|Operating Profitability KRRO|Operating Margin EDIT|SLN - Operating Return on Sales|Operating Margin PRQR (ProQR)|CDXS - Operating Sales Margin|Sangamo Therapeutics Inc. - Operating Margin|NAUT - Operating Margin|MGX: Operating Margin|Operating Sales Margin Precision BioSciences, Inc.|GBIO (Generation Bio) - Operating Margin|Boundless Bio Inc. (BOLD) - Profitability of Operations|Operating Sales Margin XCUR (exicuretx.com)|Imunon Inc - Return on Sales by Operating Profit|Operating Margin PHIO (Phio Pharmaceuticals Corp)|Operating Profit Rate MBIO|RNAZ - Operating Profitability|Operating Profit Rate BNGO (bionanogenomics.com)|Applied DNA Sciences (APDN) - Operating Profitability|Bluebird Bio - Operating Profit Rate|IPA (ImmunoPrecise Antibodies Ltd) - Operating Margin|Operating Return on Sales Omega Therapeutics, Inc. OMGA|Operating Margin OMIC|RGLS (Regulus Therapeutics Inc.) - Operating Profit Rate|Operating Margin SYRS (Syros Pharmaceuticals Inc.)|Operating Profit Ratio TBIO (Codex DNA)|TCON - Operating Profitability